Analysis of Cause-Specific Events in Competing Risks Survival Data

Publisher Summary There has been long-standing interest in competing risks, as this situation occurs frequently in a large variety of areas, including industrial engineering, demography, econometrics, and a long history of applications to biology and health. The focus is on biomedical applications, and in particular, on the analysis of individuals under treatment for cancer, who may be subject to a number of subsequent events following diagnosis and initial treatment. The chapter discusses the consideration of functions that may be estimated from competing risks data without making assumptions that cannot be verified by these data. Specifically, it considers inferences concerning cause-specific hazard functions and cumulative incidence functions, to include a discussion of hypothesis tests for comparing the cause-specific events between two groups. To present these methods, some mathematical definitions and notation are introduced. The unique feature of competing-risk problems in survival analysis is that there are both competing risks that may be correlated with the outcome of interest and a censoring mechanism that often can be assumed to be independent of the outcome of interest and, generally, of the competing risks as well. Competing-risk methods based on estimable quantities are generally straightforward and yield additional important information when multiple failure types are present.

[1]  J. D. Holt,et al.  Competing risk analyses with special reference to matched pair experiments , 1978 .

[2]  J. Klein,et al.  Independent or dependent competing risks: does it make a difference , 1987 .

[3]  A. V. Peterson,et al.  Bounds for a joint distribution function with fixed sub-distribution functions: Application to competing risks. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Margaret S. Pepe,et al.  Inference for Events with Dependent Risks in Multiple Endpoint Studies , 1991 .

[5]  Gregg E. Dinse,et al.  A note on semi-Markov models for partially censored data , 1986 .

[6]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[7]  Martin Crowder,et al.  On the Identifiability Crisis in Competing Risks Analysis , 1991 .

[8]  A. Yashin,et al.  Dependent competing risks: a stochastic process model , 1986, Journal of mathematical biology.

[9]  D. Harrington,et al.  Counting Processes and Survival Analysis , 1991 .

[10]  R. Peto,et al.  Asymptotically efficient rank invariant test procedure (with discussion). , 1972 .

[11]  Robert Gray,et al.  A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .

[12]  Dario Gasbarra,et al.  Testing equality of cause-specific hazard rates corresponding to m competing risks among K groups , 2002 .

[13]  Lagakos Sw General right censoring and its impact on the analysis of survival data. , 1979 .

[14]  Jeffrey J. Gaynor,et al.  On the Use of Cause-Specific Failure and Conditional Failure Probabilities: Examples from Clinical Oncology Data , 1993 .

[15]  M S Pepe,et al.  Weighted Kaplan-Meier statistics: a class of distance tests for censored survival data. , 1989, Biometrics.

[16]  Odd Aalen,et al.  Nonparametric Estimation of Partial Transition Probabilities in Multiple Decrement Models , 1978 .

[17]  E L Korn,et al.  Applications of crude incidence curves. , 1992, Statistics in medicine.

[18]  C. L. Chiang,et al.  Introduction to stochastic processes in biostatistics. , 1968 .

[19]  V T Farewell,et al.  The analysis of failure times in the presence of competing risks. , 1978, Biometrics.

[20]  J. Peto,et al.  Asymptotically Efficient Rank Invariant Test Procedures , 1972 .

[21]  Norman Wolmark,et al.  Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  M S Pepe,et al.  Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data? , 1993, Statistics in medicine.

[23]  H. A. David The theory of competing risks , 1980 .

[24]  Clelia Di Serio,et al.  The Protective Impact of a Covariate on Competing Failures with an Example from a Bone Marrow Transplantation Study , 1997 .

[25]  D. Lin,et al.  Non-parametric inference for cumulative incidence functions in competing risks studies. , 1997, Statistics in medicine.

[26]  Simeon M. Berman,et al.  Note on Extreme Values, Competing Risks and Semi-Markov Processes , 1963 .

[27]  J. Bryant,et al.  Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancer: the National Surgical Adjuvant Breast and Bowel Project Experience. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  J Benichou,et al.  Estimates of absolute cause-specific risk in cohort studies. , 1990, Biometrics.

[29]  J. Fine,et al.  Regression modeling of competing crude failure probabilities. , 2001, Biostatistics.

[30]  L. Weissfeld,et al.  Methods for bounding the marginal survival distribution. , 1995, Statistics in medicine.

[31]  Rupert G. Miller,et al.  Survival Analysis , 2022, The SAGE Encyclopedia of Research Design.

[32]  Gregg E. Dinse,et al.  A mixture model for the regression analysis of competing risks data , 1985 .

[33]  Lee-Jen Wei,et al.  Prediction of cumulative incidence function under the proportional hazards model. , 1998, Biometrics.

[34]  R. Gray A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk , 1988 .

[35]  David R. Cox,et al.  Regression models and life tables (with discussion , 1972 .

[36]  D. Cox,et al.  THE ANALYSIS OF EXPONENTIALLY DISTRIBUTED LIFE-TIMES WITH Two TYPES OF FAILURE , 1959 .

[37]  Wayne Nelson Theory and applications of hazard plotting for censored failure data , 2000 .

[38]  D. Harrington A class of rank test procedures for censored survival data , 1982 .

[39]  J Crowley,et al.  Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. , 1999, Statistics in medicine.

[40]  T. Pajak,et al.  Analysis of the probability and risk of cause-specific failure. , 1994, International journal of radiation oncology, biology, physics.

[41]  E. Gehan A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES. , 1965, Biometrika.

[42]  Yuri K Belyaev,et al.  A Class of Non‐parametric Tests in the Competing Risks Model for Comparing Two Samples , 1998 .

[43]  James J. Heckman,et al.  The identifiability of the competing risks model , 1989 .

[44]  J. Kalbfleisch,et al.  The Statistical Analysis of Failure Time Data , 1980 .

[45]  E. Slud,et al.  How dependent causes of death can make risk factors appear protective. , 1988, Biometrics.

[46]  James J Dignam,et al.  Semiparametric Models for Cumulative Incidence Functions , 2004, Biometrics.

[47]  N. Mantel Evaluation of survival data and two new rank order statistics arising in its consideration. , 1966, Cancer chemotherapy reports.

[48]  N. L. Johnson,et al.  Survival Models and Data Analysis , 1982 .